Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1827-1831, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogler, W. R.
Right arrow Articles by Huguley, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogler, W. R.
Right arrow Articles by Huguley, C. M., Jr.

In Vivo Effect of Hydroxyurea on Orotic Acid Synthesis1

William R. Vogler, James A. Bain and Charles M. Huguley, Jr.

The Department of Medicine, School of Medicine, and the Department of Pharmacology, Division of Basic Health Sciences, Emory University, Atlanta, Georgia

Hydroxyurea is thought to inhibit DNA synthesis but the site of inhibition has not been established. The urinary excretion of orotic acid was measured in 6 patients, 5 with acute leukemia and 1 with metastatic melanoma, receiving 6-azauridine which is known to inhibit orotidylic decarboxylase. The orotic aciduria observed in these patients was reversed by the addition of hydroxyurea, suggesting inhibition of de novo pyrimidine biosynthesis at a step prior to the formation of orotic acid. No clear-cut potentiation of a chemotherapeutic effect of this combination of drugs was observed.

1 A preliminary report was made to the American Association for Cancer Research, Philadelphia, April 1965 (Proc. Am. Assoc. Cancer Res., 6: 67, 1965). This investigation was supported in part by USPHS Research Grants No. CA-05733-03, -04, and CA-03227-08, -09 from the National Cancer Institute and by Grant No. FR-39 from the Division of Research Facilities and Resources, NIH.

Received 1/10/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.